SARS
Disease caused by severe acute respiratory syndrome coronavirus
SARS ▸ Facts ▸ Comments ▸ News ▸ Videos
Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by the virus SARS-CoV-1, the first identified strain of the SARS-related coronavirus. The first known cases occurred in November 2002, and the syndrome caused the 2002–2004 SARS outbreak. In the 2010s, Chinese scientists traced the virus through the intermediary of Asian palm civets to cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan.
| 0 shares | ShareTweetSavePostSend |
You Might Like
​JN.1 not expected to spread as existing Covid-19 vaccine will work: Ex-ICMR DGThe JN.1 variant of the SARS-COV-2 virus is not expected to spread widely in India. Existing Covid-19 vaccines and mask-wearing in crowded places should be sufficient to combat it. The government is..IndiaTimes - Published | |
Evidence of viral resistance to Covid-19 drug Paxlovid foundA new research provided evidence of viral resistance to Paxlovid among SARS-CoV-2 variants currently circulating globally, indicating that this stand-alone drug could soon become less effective in..IndiaTimes - Published | |
Vaccination halves risk of long Covid, study showsBeing vaccinated against the SARS-CoV-2 virus halves people's risk of developing long Covid, according to the largest study of its kind. The research, published in the journal JAMA Internal Medicine,..IndiaTimes - Published | |
India gets first nasal Covid vaccine: How it can be the 'game changer'Centre on Thursday launched India's first nasal Covid-19 vaccine iNCOVACC. Bharat Biotech's Incovacc received government approval for use as a booster dose in the country-wide mass inouclation program...IndiaTimes - Published | |
India isolates BF.7 strain, to test efficacy of Covid-19 vaccinesIndia has successfully isolated a sample of SARS-CoV-2 virus containing the BF.7, a sub-lineage of the Omicron variant, which is suspected to be behind the surge in Covid-19 cases in several countries..IndiaTimes - Published | |
India-made drug shows promise in treating Covid heart damageA drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has..IndiaTimes - Published | |
CEPI partners consortium of Bharat Biotech, Sydney University & ExcellGene to develop variant-proof SARS-CoV-2 vaccineIndiaTimes - Published | |
Asthma drug can block crucial SARS-CoV-2 protein: IIScIndiaTimes - Published | |
Covid-19: Fourth wave could occur in India but not yet, feel expertsWhile the Omicron subvariant BA2 has caused a huge surge in South Korea and Europe, Indian experts are not worried about it triggering another wave in the country right away. Their reasons include..IndiaTimes - Published | |
Inhaling Nitric Oxide can kill Covid-19 causing SARS-CoV-2 virus? New study gives insightThe team of experts at Amrita Hospital decided to conduct this trial on a small group of Covid patients admitted at Amrita Hospital.DNA - Published | |
Scientists identify antibodies that might neutralize OmicronDuring a recent study, an international team of scientists identified antibodies that neutralize Omicron and other SARS-CoV-2 variants.These antibodies target areas of the virus spike protein that..IndiaTimes - Published | |
Top Indian Scientist warns against thinking Omicron strain causes mild diseaseThe Institute of Genomics and Integrative Biology has been sequencing the SARS-CoV-2 genes to detect Omicron and understand how it works.DNA - Published | |
Variant worry: PM Modi seeks review of plan to ease international travel curbsPrime Minister Narendra Modi on Saturday said there is a need to be proactive in the light of the new SARS-CoV-2 “variant of concern” Omicron and directed officials to review plans for easing of..IndiaTimes - Published | |
